Paul Bikard

Paul Bikard currently serves as Chief Financial Officer at Accure Therapeutics and is a Board Member at Medevise, contributing to a team focused on the ophthalmic industry in Europe. In addition, Paul Bikard is President of Mampa CF, providing management and financial consulting for the biotech sector. Previous roles include CFO at SENSORION, CFO at Transgene, and COO/CFO at Prestwick Chemical, alongside managerial positions at Arthur Andersen and Price Waterhouse Coopers. Paul Bikard holds an education from emlyon business school and Collège Kennedy Mulhouse.